#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15352	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2046	745.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1440	1440	C	924	C,A	868,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15352	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2046	745.4	0	HET	.	.	.	C451T,A	.	451	451	C	707	707	C	908	C,T,A	608,244,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27888	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3700	751.9	0	.	n	.	0	T695C	SNP	695	695	T	1127	1127	C	877	C,T	829,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27888	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3700	751.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2403	2403	C	919	C	849	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27888	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3700	751.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2477	2477	A	900	A	832	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27888	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3700	751.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3029	3029	C	878	C	818	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27888	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3700	751.9	0	HET	.	.	.	A1638G	.	1638	1638	A	2070	2070	A	870	A,G	626,179	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2028	folP	855	855	100.0	folP.l15.c30.ctg.1	1578	128.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1078	1080	AGC	189;188;188	A;G;C	176;175;174	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5588	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3463	161.0	1	SNP	p	S91F	1	.	.	271	273	TTC	583	585	TTC	187;189;192	T;T;C	177;179;179	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5588	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3463	161.0	1	SNP	p	D95G	1	.	.	283	285	GGC	595	597	GGC	201;202;202	G;G;C	180;180;182	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5588	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3463	161.0	1	SNP	p	G95N	0	.	.	283	285	GGC	595	597	GGC	201;202;202	G;G;C	180;180;182	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1672	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1395	119.4	1	SNP	p	G45D	0	.	.	133	135	GGC	447	449	GGC	201;197;196	G;G;C	187;184;181	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	754	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	978	76.8	0	.	n	.	0	A197.	DEL	197	197	A	530	530	A	184	A	177	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5840	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3022	192.5	1	SNP	p	D86N	0	.	.	256	258	GAC	585	587	GAC	227;230;230	G;A;C	213;214;217	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5840	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3022	192.5	1	SNP	p	S87R	1	.	.	259	261	CGT	588	590	CGT	229;224;222	C;G;T	216;213;207	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5840	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3022	192.5	1	SNP	p	R87W	0	.	.	259	261	CGT	588	590	CGT	229;224;222	C;G;T	216;213;207	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5840	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3022	192.5	1	SNP	p	R87I	0	.	.	259	261	CGT	588	590	CGT	229;224;222	C;G;T	216;213;207	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5840	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3022	192.5	1	SNP	p	S88P	0	.	.	262	264	TCC	591	593	TCC	222;225;228	T;C;C	207;208;216	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4066	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2638	153.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1504	1506	GGC	184;181;183	G;G;C	176;171;170	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2419	160.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1267	1269	GCC	206;207;204	G;C;C	191;191;189	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2419	160.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1270	1272	ATG	205;205;206	A;T;G	191;189;189	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2419	160.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1282	1284	ACC	195;196;198	A;C;C	182;182;186	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2419	160.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1282	1284	ACC	195;196;198	A;C;C	182;182;186	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2419	160.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1783	1785	ACC	200;201;200	A;C;C	179;183;190	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2419	160.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1837	1839	GCG	208;207;211	G;C;G,A	192;194;197,1	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2419	160.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1837	1839	GCG	208;207;211	G;C;G,A	192;194;197,1	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2419	160.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1960	1962	GGT	166;167;169	G;G;T	151;151;152	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2419	160.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1969	1971	AGC	164;165;165	A;G;C	147;150;147	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2419	160.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1987	1989	CCG	150;151;147	C,G;C,G;G,GGCC	120,6;119,2;118,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6112	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3122	195.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1646	1648	CCG	227;228;226	C;C,T;G	207;213,1;204	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2458	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1800	135.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	560	560	C	166	C	155	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2912	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1638	177.0	1	SNP	p	G120K	1	.	.	358	360	AAG	694	696	AAG	216;219;219	A;A;G	205;209;201	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2912	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1638	177.0	1	SNP	p	N121D	0	.	.	361	363	AAC	697	699	AAC	220;218;216	A;A;C	207;203;205	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2912	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1638	177.0	1	SNP	p	A121N	1	.	.	361	363	AAC	697	699	AAC	220;218;216	A;A;C	207;203;205	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	348	porB3	990	303	90.71	porB3.l6.c30.ctg.2	358	45.0	0	.	p	.	0	S217G	NONSYN	649	651	AGC	57	59	GGC	19;19;16	G;G;C	10;10;9	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	348	porB3	990	303	90.71	porB3.l6.c30.ctg.2	358	45.0	0	.	p	.	0	D222N	NONSYN	664	666	GAT	72	74	AAT	18;18;17	A;A;T	13;15;14	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	348	porB3	990	303	90.71	porB3.l6.c30.ctg.2	358	45.0	0	.	p	.	0	V230A	NONSYN	688	690	GTA	96	98	GCA	23;22;22	G;C;A,T	23;22;21,1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	348	porB3	990	303	90.71	porB3.l6.c30.ctg.2	358	45.0	0	.	p	.	0	V238Y	NONSYN	712	714	GTT	120	122	TAT	25;25;25	T;A;T	23;25;25	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	348	porB3	990	303	90.71	porB3.l6.c30.ctg.2	358	45.0	0	.	p	.	0	.	INDELS	715	717	GAA	124	130	GAGCAAT	25;25;25;26;26;26;26	G;A;G;C;A;A;T	25;25;25;26;26;26;26	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	348	porB3	990	303	90.71	porB3.l6.c30.ctg.2	358	45.0	0	.	p	.	0	.	INDELS	719	720	AC	133	135	GCG	35;36;36	G;C;G	31;32;32	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	348	porB3	990	303	90.71	porB3.l6.c30.ctg.2	358	45.0	0	.	p	.	0	L253V	NONSYN	757	759	TTG	174	176	GTA	41;41;41	G;T;A	40;40;41	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	348	porB3	990	303	90.71	porB3.l6.c30.ctg.2	358	45.0	0	.	p	.	0	S273T	NONSYN	817	819	TCG	234	236	ACT	58;59;58	A,T;C;T	48,1;50;51	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	348	porB3	990	303	90.71	porB3.l6.c30.ctg.2	358	45.0	0	.	p	.	0	K278N	NONSYN	832	834	AAA	249	251	AAC	52;55;57	A,G;A;C	49,1;52;53	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	348	porB3	990	303	90.71	porB3.l6.c30.ctg.2	358	45.0	0	.	p	.	0	R279H	NONSYN	835	837	CGC	252	254	CAC	59;63;66	C,T;A;C	54,1;56;60	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11004	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4693	233.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1136	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1024	109.9	1	SNP	p	V57M	1	.	.	169	171	ATG	509	511	ATG	224;227;224	A;T;G	212;214;211	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
